What is a cure through gene therapy? An analysis and evaluation of the use of "cure"

被引:2
|
作者
Baas, Lieke [1 ]
Meijer, Karina [2 ]
Bredenoord, Annelien L. [3 ]
van der Graaf, Rieke [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Bioeth & Hlth Humanities, Utrecht, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[3] Erasmus Univ, Erasmus Sch Philosophy, Rotterdam, Netherlands
关键词
Health; Disease; Cure; Gene therapy; Ethics; Philosophy of medicine; C VIRUS-INFECTION; WORD CURE; HEMOPHILIA; RECOVERY; IDENTITY; DISEASE; MODEL;
D O I
10.1007/s11019-024-10223-w
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The development of gene therapy has always come with the expectation that it will offer a cure for various disorders, of which hemophilia is a paradigm example. However, although the term is used regularly, it is unclear what exactly is meant with "cure". Therefore, the aim of this paper is to analyse how the concept of cure is used in practice and evaluate which of the interpretations is most suitable in discussions surrounding gene therapy. We analysed how cure is used in four different medical fields where the concept raises discussion. We show that cure can be used in three different ways: cure as normalization of the body, cure as obtaining a normal life, or cure as a change in identity. We argue that since cure is a practical term, its interpretation should be context-specific and the various uses can exist simultaneously, as long as their use is suitable to the function the notion of cure plays in each of the settings. We end by highlighting three different settings in the domain of hemophilia gene therapy in which the term cure is used and explore the function(s) it serves in each setting. We conclude that in the clinical application of gene therapy, it could be better to abandon the term cure, whereas more modest and specified definitions of cure are required in the context of health resource allocation decisions and decisions on research funding.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [41] Allogeneic Transplant and Gene Therapy Evolving Toward a Cure
    Lawal, R. AdeBisi
    Walters, Mark C.
    Fitzhugh, Courtney D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (06) : 1313 - 1335
  • [42] Gene therapy for pulmonary arterial hypertension: is a cure in sight?
    Mathew, Rajamma
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 129 - 131
  • [43] Treatment to cure: Advancing AAV gene therapy manufacture
    Young, Paul
    DRUG DISCOVERY TODAY, 2023, 28 (07)
  • [44] Prenatal gene therapy offers the earliest possible cure
    DeWeerdt S.
    Nature, 2018, 564 (7735) : S6 - S8
  • [45] Gene therapy for prevention and cure of type 1 diabetes
    Harrison, LC
    JOURNAL OF GENE MEDICINE, 2005, 7 (08): : 1118 - 1118
  • [46] Gene Therapy in Cardiology: Is a Cure for Hypertrophic Cardiomyopathy on the Horizon?
    Paratz, Elizabeth D.
    Mundisugih, Juan
    Rowe, Stephanie J.
    Kizana, Eddy
    Semsarian, Christopher
    CANADIAN JOURNAL OF CARDIOLOGY, 2024, 40 (05) : 777 - 788
  • [47] Gene therapy trials for haemophilia: a step closer to a cure?
    Batty, Paul
    Pasi, K. John
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (05): : 259 - 262
  • [48] Cure following gene therapy for recurrent glioblastoma multiforme?
    Karabatsou, K.
    Bernstein, M.
    ACTA NEUROCHIRURGICA, 2008, 150 (06) : 611 - 612
  • [49] CURE THROUGH SUGGESTION
    Campbell, N. D.
    PSYCHOANALYTIC REVIEW, 1936, 23 (03): : 346 - 346
  • [50] Regarding therapy for agranulocytosis (Cure by use of leucaemic blood)
    Deglmann, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1937, 63 : 1694 - 1696